Kosiborod MN, Bhatta M, Davies M, Deanfield JE, et al. Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses. Diabetes Obes Metab 2023;25:468-478.
PMID: 36200477